Home Data Calendar Blog

ACET

Tables

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Common Stock Value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

dei: Entity Common Stock Shares Outstanding NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Weighted Average Number Of Diluted Shares Outstanding NA 41.64 40.08 45.96 NA 31.88 31.82 26.10 NA NA NA NA NA NA

Weighted Average Number Of Shares Outstanding Basic NA 41.64 40.08 39.82 NA 31.88 31.82 26.10 NA NA NA NA NA NA

Earnings Per Share Basic -0.72 -0.53 -0.56 0.12 -0.46 -0.44 -0.34 -0.82 NA NA NA NA NA NA

Earnings Per Share Diluted -0.72 -0.53 -0.56 0.10 -0.46 -0.44 -0.34 -0.82 NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Revenues 0.00 0.00 0.00 24.99 5.47 3.43 4.81 -3.98 5.41 3.03 7.46 2.00 1.97 -7.05

Operating Expenses 31.57 22.98 22.71 20.28 21.01 17.14 15.64 17.37 14.76 16.68 5.65 7.38 29.44 25.16

Research And Development Expense 25.02 16.57 16.18 13.48 14.66 11.93 10.62 11.74 9.68 8.94 1.79 4.84 26.11 22.12

General And Administrative Expense 6.55 6.42 6.53 6.80 6.35 5.21 5.03 5.63 5.08 7.74 3.86 2.54 3.33 3.04

Operating Income Loss -31.57 -22.98 -22.71 4.71 -15.54 -13.71 -10.83 -21.35 -9.35 -13.65 -5.65 -7.38 -29.44 -25.16

Interest Expense 0.03 0.02 0.02 0.02 0.03 0.05 0.05 0.05 0.05 0.05 0.03 NA NA NA

Allocated Share Based Compensation Expense 4.25 4.19 4.33 4.35 4.28 2.53 2.66 3.04 1.65 2.97 0.35 0.30 0.31 0.39

Profit Loss -29.88 -22.00 -22.54 4.62 -15.81 -14.01 -10.85 -21.32 -8.96 -15.08 -5.60 -7.04 -28.89 -24.45

Net Income Loss -29.88 -22.00 -22.54 4.62 -15.81 -14.01 -10.85 -21.32 -8.96 -14.78 -5.60 -7.04 -28.89 -24.45

Comprehensive Income Net Of Tax -29.88 -22.00 -22.54 4.62 -15.81 -14.01 -10.86 -21.34 -9.02 -14.89 -5.63 -7.05 -28.95 -24.51

Net Income Loss Available To Common Stockholders Basic -29.88 -22.00 -22.54 4.62 -15.81 -14.01 -10.85 -21.32 -8.96 -14.78 -8.46 -4.49 -6.58 -14.78

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Assets 330.69 354.30 329.90 340.45 338.94 257.19 268.78 282.07 153.84 150.40 74.34 78.21 93.91 121.96

Liabilities 38.35 36.65 36.64 29.37 35.81 39.97 40.44 45.81 44.01 33.47 3.60 2.59 12.21 12.20

Liabilities And Stockholders Equity 330.69 354.30 329.90 340.45 338.94 257.19 268.78 282.07 153.84 150.40 74.34 78.21 93.91 121.96

Stockholders Equity 292.34 317.66 293.27 311.08 303.13 217.22 228.34 236.26 109.83 116.93 70.74 75.62 81.70 109.76

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Assets Current 261.04 285.74 264.09 281.53 282.44 199.03 216.30 229.11 100.34 117.41 73.75 77.58 93.25 121.28

Cash And Cash Equivalents At Carrying Value 257.66 282.68 260.64 277.88 277.54 192.23 208.73 221.67 84.33 84.96 70.89 61.23 33.77 23.62

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 257.66 282.68 260.64 278.03 277.69 196.75 213.25 226.44 88.86 89.49 71.13 61.48 34.02 27.29

Other Assets Current 0.38 0.38 0.73 0.04 0.00 0.00 0.37 0.12 0.36 0.06 NA 0.00 0.07 0.02

Prepaid Expense And Other Assets Current 3.38 3.03 3.45 3.65 4.71 6.80 7.58 5.69 5.72 9.29 2.86 NA 1.78 NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Property Plant And Equipment Gross 37.46 34.52 30.21 24.37 20.97 17.36 10.44 8.31 7.65 6.59 0.57 0.57 0.57 0.58

Leasehold Improvements Gross 18.40 16.20 16.20 NA NA NA NA NA NA NA NA NA NA NA

Construction In Progress Gross 9.30 NA NA NA NA NA NA NA NA NA NA NA NA NA

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 8.75 7.69 7.04 6.64 6.33 5.96 5.65 5.19 4.86 4.55 0.23 0.19 0.16 0.14

Property Plant And Equipment Net 28.71 26.83 23.17 17.74 14.64 11.39 4.79 3.12 2.79 2.04 0.35 0.38 0.41 0.44

Goodwill 19.46 19.46 19.46 19.46 19.46 19.46 19.46 19.86 20.09 20.74 NA NA NA NA

Other Assets Noncurrent 1.21 1.28 1.79 1.86 1.89 1.92 2.00 2.10 1.84 2.19 NA NA 0.41 NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Liabilities Current 19.71 17.22 16.40 10.40 16.32 20.03 20.95 25.18 22.48 30.08 3.56 2.56 12.20 12.19

Accounts Payable Current 4.40 4.57 4.15 3.46 3.26 4.63 2.32 1.75 1.55 3.84 2.47 1.21 6.72 9.97

Other Accrued Liabilities Current 0.03 0.18 0.08 0.05 0.50 0.04 0.04 0.03 0.33 0.83 0.36 0.11 0.15 0.17

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Other Liabilities Noncurrent 0.11 0.12 0.12 0.12 0.12 0.12 NA NA NA 0.04 0.03 0.02 0.01 0.01

Operating Lease Liability Noncurrent 18.53 19.31 20.12 18.85 19.38 19.82 19.49 19.95 20.42 NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Stockholders Equity 292.34 317.66 293.27 311.08 303.13 217.22 228.34 236.26 109.83 116.93 70.74 75.62 81.70 109.76

Common Stock Value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Additional Paid In Capital Common Stock 530.45 525.89 479.51 474.79 471.45 369.73 366.84 363.90 216.13 214.21 237.51 236.75 235.78 234.89

Retained Earnings Accumulated Deficit -238.11 -208.24 -186.24 -163.71 -168.32 -152.51 -138.50 -127.64 -106.33 -97.37 -166.77 -161.17 -154.13 -125.24

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value NA 4.19 4.33 4.35 NA 2.53 2.66 3.04 NA 2.97 0.76 0.97 NA 1.20

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Net Cash Provided By Used In Operating Activities -18.84 -15.33 -14.71 4.11 -13.44 -9.68 -12.78 -15.15 -13.35 -7.82 -5.34 -15.04 -25.65 -21.65

Net Cash Provided By Used In Investing Activities -6.49 -4.81 -2.85 -2.63 -3.08 -7.18 -0.38 7.84 12.45 45.27 15.00 42.50 35.97 17.81

Net Cash Provided By Used In Financing Activities 0.30 42.18 0.16 -1.13 97.46 0.36 -0.03 144.89 0.27 0.04 -0.00 -0.00 -0.01 6.09

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Net Cash Provided By Used In Operating Activities -18.84 -15.33 -14.71 4.11 -13.44 -9.68 -12.78 -15.15 -13.35 -7.82 -5.34 -15.04 -25.65 -21.65

Net Income Loss -29.88 -22.00 -22.54 4.62 -15.81 -14.01 -10.85 -21.32 -8.96 -14.78 -5.60 -7.04 -28.89 -24.45

Profit Loss -29.88 -22.00 -22.54 4.62 -15.81 -14.01 -10.85 -21.32 -8.96 -15.08 -5.60 -7.04 -28.89 -24.45

Increase Decrease In Accounts Payable 1.15 1.74 -0.57 -0.61 -1.94 2.31 0.57 0.20 -2.26 5.69 1.25 -5.51 -3.25 1.78

Share Based Compensation 4.25 4.19 4.33 4.35 4.28 2.53 2.66 3.04 1.65 1.88 0.76 0.97 0.89 1.20

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Net Cash Provided By Used In Investing Activities -6.49 -4.81 -2.85 -2.63 -3.08 -7.18 -0.38 7.84 12.45 45.27 15.00 42.50 35.97 17.81

Payments To Acquire Property Plant And Equipment 6.49 4.81 2.85 2.63 3.08 7.18 2.13 0.66 0.36 0.22 0.12 0.29 0.03 0.19

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Net Cash Provided By Used In Financing Activities 0.30 42.18 0.16 -1.13 97.46 0.36 -0.03 144.89 0.27 0.04 -0.00 -0.00 -0.01 6.09

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30

Revenues 0.00 0.00 0.00 24.99 5.47 3.43 4.81 -3.98 5.41 3.03 7.46 2.00 1.97 -7.05

Regeneron Pharmaceuticals Incorporation 0.00 0.00 0.00 25.00 5.40 3.40 4.80 4.00 5.40 3.00 7.50 NA 2.00 -7.00

Plots across concepts

IncomeStatement

Operating Income Loss

Expenses

Other Nonoperating Income Expense

Balance Sheet

Operating Lease Right Of Use Asset

Assets

Operating Lease Right Of Use Asset

Current Assets

Other Assets Current

NonCurrent Assets

Other Assets Noncurrent

PropertyPlantAndEquipmentNet

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

Liabilities

Liabilities Current

Current Liabilities

Other Accrued Liabilities Current

Stockholders Equity

Retained Earnings Accumulated Deficit

CashFlow

Net Income Loss

NetCashProvidedByUsedInOperatingActivities

Net Income Loss

NetCashProvidedByUsedInInvestingActivities

Net Cash Provided By Used In Investing Activities

Shares

Common Stock Shares Outstanding

OperatingLeaseLiability

Operating Lease Liability Current

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Undiscounted Excess Amount

Line plots across dimensions of each concept

TTM Greenblatt ROC
_
(None,)

T T M Greenblatt R O C_

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)

Allocated Share Based Compensation Expenseus-gaap: Income Statement Location

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)

Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components